Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lonafarnib for cancer and progeria.
Wong NS, Morse MA. Wong NS, et al. Among authors: morse ma. Expert Opin Investig Drugs. 2012 Jul;21(7):1043-55. doi: 10.1517/13543784.2012.688950. Epub 2012 May 24. Expert Opin Investig Drugs. 2012. PMID: 22620979 Review.
A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer.
Wong NS, Meadows KL, Rosen LS, Adjei AA, Kaufmann SH, Morse MA, Petros WP, Zhu Y, Statkevich P, Cutler DL, Meyers ML, Hurwitz HI. Wong NS, et al. Among authors: morse ma. Cancer Invest. 2011 Nov;29(9):617-25. doi: 10.3109/07357907.2011.621912. Cancer Invest. 2011. PMID: 22011284 Free PMC article. Clinical Trial.
DC-CIK as a widely applicable cancer immunotherapy.
Wang S, Wang X, Zhou X, Lyerly HK, Morse MA, Ren J. Wang S, et al. Among authors: morse ma. Expert Opin Biol Ther. 2020 Jun;20(6):601-607. doi: 10.1080/14712598.2020.1728250. Epub 2020 Feb 13. Expert Opin Biol Ther. 2020. PMID: 32033522 Review.
Combining cancer vaccines with chemotherapy.
Chong G, Morse MA. Chong G, et al. Among authors: morse ma. Expert Opin Pharmacother. 2005 Dec;6(16):2813-20. doi: 10.1517/14656566.6.16.2813. Expert Opin Pharmacother. 2005. PMID: 16318432 Review.
Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors.
Castaneda C, Meadows KL, Truax R, Morse MA, Kaufmann SH, Petros WP, Zhu Y, Statkevich P, Cutler DL, Hurwitz HI. Castaneda C, et al. Among authors: morse ma. Cancer Chemother Pharmacol. 2011 Feb;67(2):455-63. doi: 10.1007/s00280-010-1488-5. Epub 2010 Oct 24. Cancer Chemother Pharmacol. 2011. PMID: 20972873 Clinical Trial.
402 results